{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:41:05Z","timestamp":1792114865054,"version":"4.4.0"},"reference-count":99,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Empire Clinical Research Investigator Program (ECRIP)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The thyroid is a vital endocrine organ that regulates metabolism, heart rate, respiration, digestion, body temperature, brain development, skin and bone maintenance, and reproduction and fertility. Thyroid cancer (TC) is the most common endocrine malignancy, with an estimate of 44,020 new cases in 2025. Incidence has been increasing, most notably at 4\u20135% per year in young adults. Papillary thyroid cancer (PTC), the most common TC subtype, accounts for approximately 80% of newly diagnosed TC cases. Furthermore, 2290 deaths are expected from the disease in 2025, with survival at over 98% with treatment. However, as PTC occurs most frequently in young women, recurrences are frequent and the 10-year disease-specific survival rate for advanced PTC is less than 50%. This narrative review aims to describe the current understanding of the thyroid gland, the incidence and subtypes of thyroid cancer, and specifically the diagnosis, prognosis, treatment, and recurrence of PTC. This is supplemented by the role of molecular pathways and biomarkers in PTC.<\/jats:p>","DOI":"10.3390\/ijms26104646","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T06:40:23Z","timestamp":1747118423000},"page":"4646","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Current Understanding of the Molecular Pathogenesis of Papillary Thyroid Cancer"],"prefix":"10.3390","volume":"26","author":[{"given":"Michelle","family":"Carnazza","sequence":"first","affiliation":[{"name":"Division of R&D, General Nutraceutical Technology, LLC, Elmsford, NY 10523, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Quaranto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"DeSouza","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine L.","family":"Moscatello","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garber","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hemmerdinger","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humayun K.","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA"},{"name":"Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K.","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA"},{"name":"Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA"},{"name":"Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA"},{"name":"Department of Dermatology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-7960","authenticated-orcid":false,"given":"Jan","family":"Geliebter","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA"},{"name":"Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"ref_1","unstructured":"Feingold, K., Ahmed, S.F., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., and Dungan, K. (2015). Chapter 21 surgery of the thyroid. Endotext [Internet], MDText.com, Inc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1242\/dev.145615","article-title":"Development of the thyroid gland","volume":"144","author":"Nilsson","year":"2017","journal-title":"Development"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2017.01.025","article-title":"The classic pathways of thyroid hormone metabolism","volume":"458","author":"Fliers","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.beem.2013.05.012","article-title":"Determination of free thyroid hormones","volume":"27","author":"Thienpont","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid Hormone Regulation of Metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.eprac.2023.08.006","article-title":"Prevalence and trends of thyroid disease among adults, 1999\u20132018","volume":"29","author":"Zhang","year":"2023","journal-title":"Endocr. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/pir.2020-001420","article-title":"Thyroid Disorders","volume":"42","author":"Alarcon","year":"2021","journal-title":"Pediatr. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/jpem-2023-0040","article-title":"Thyroid\u2014What is a healthy thyroid function test?","volume":"36","author":"Kiess","year":"2023","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamapediatrics.2016.0486","article-title":"Thyroid disorders in children and adoelscents: A review","volume":"170","author":"Hanley","year":"2016","journal-title":"JAMA Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semcancer.2019.05.019","article-title":"Thyroid autoimmune disorders and cancer","volume":"64","author":"Ferrari","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on Fundamental Mechanisms of Thyroid Cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"1","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21637","article-title":"Cancer statistics for adolescents and young adults","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3322\/caac.21195","article-title":"New developments in the diagnosis and treatment of thyroid cancer","volume":"63","author":"Schneider","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"ref_17","first-page":"3","article-title":"Thyroid Carcinoma: Epidemiology, Histology, and Diagnosis","volume":"13","author":"Shah","year":"2015","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Giani, F., Vella, V., Tumino, D., Maladrino, P., and Frasca, F. (2020). The Possible Role of Cancer Stem Cells in the Resistance to Kinase Inhibitors of Advanced Thyroid Cancer. Cancers, 12.","DOI":"10.3390\/cancers12082249"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2328171","DOI":"10.1001\/jamanetworkopen.2023.28171","article-title":"Patterns in cancer incidence among people younger than 50 years in the US, 2010\u20132019","volume":"6","author":"Koh","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ijc.33537","article-title":"Thyroid cancer and its associated factors: A population-based case-control study","volume":"149","author":"Parad","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_21","unstructured":"N. C. I. Surveillance Research Program (2023, December 10). SEER*Explorer: An Interactive Website for SEER Cancer Statistics, Available online: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e100472","DOI":"10.1016\/j.coemr.2023.100472","article-title":"Thyroid cancer incidence differences between men and women","volume":"31","author":"Tran","year":"2023","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/ERC-14-0053","article-title":"Estrogen and its role in thyroid cancer","volume":"21","author":"Derwahl","year":"2014","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"663130","DOI":"10.3389\/fcell.2021.663130","article-title":"Androgen Activity Is Associated With PD-L1 Downregulation in Thyroid Cancer","volume":"9","author":"Dadafarin","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jcb.29934","article-title":"Andorgen receptor activation decreases proliferation in thyroid cancer cells","volume":"122","author":"Jones","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gupta, A., Carnazza, M., Jones, M., Darzynkiewicz, Z., Halicka, D., O\u2019Connell, T., Zhao, H., Dadafarin, S., Shin, E., and Schwarcz, M.D. (2023). Androgen receptor activation induces senescence in thyroid cancer cells. Cancers, 15.","DOI":"10.3390\/cancers15082198"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1320690","DOI":"10.3389\/fmedt.2024.1320690","article-title":"Sex-specific outcomes in cancer therapy: The central role of hormones","volume":"6","author":"Bakshi","year":"2024","journal-title":"Front. Med. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Aurilio, G., Cimadamore, A., Mazzucchelli, R., Lopez-Beltran, A., Verri, E., Scarpelli, M., Massari, F., Cheng, L., Santoni, M., and Montironi, R. (2020). Androgen receptor signaling pathway in prostate cancer: From genetics to clinical applications. Cells, 9.","DOI":"10.3390\/cells9122653"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/978-0-387-78818-0_10","article-title":"Endogenous hormone levels and risk of breast, endometrial, and ovarian cancers: Prospective studies","volume":"630","author":"Eliassen","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.21037\/gs-21-545","article-title":"Sex disparities in thyroid cancer: A SEER population study","volume":"10","author":"Li","year":"2021","journal-title":"Gland Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/jamainternmed.2021.4804","article-title":"Evaluation of gender inequity in thyroid cancer diagnosis","volume":"181","author":"LeClair","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2374289519851218","DOI":"10.1177\/2374289519851218","article-title":"Educational Case: Cytology for Staging Neoplasia and Thyroid Neoplasms","volume":"6","author":"McGary","year":"2019","journal-title":"Acad. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejso.2017.05.002","article-title":"Evolutin of histologic classification of thyroid neoplasms and its impact on clinical management","volume":"44","author":"Xu","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Network","year":"2014","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cyt.12492","article-title":"Molecular pathology and thyroid FNA","volume":"28","author":"Poller","year":"2017","journal-title":"Cytopathology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.14310\/horm.2002.1677","article-title":"Which is the best predictor of thyroid cancer: Thyroptropin, thyroglobulin, or their ratio?","volume":"15","author":"Yazici","year":"2016","journal-title":"Hormones"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1029926","DOI":"10.3389\/fonc.2022.1029926","article-title":"Mapping global epidemiology of thyroid nodules among general population: A systemic review and meta-analysis","volume":"12","author":"Mu","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_39","first-page":"1039","article-title":"The 2023 Bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/his.13335","article-title":"Crucial parameteres in thyroid carcinoma reporting- challenges, controversies, and clinical implications","volume":"72","author":"Xu","year":"2018","journal-title":"Histopathology"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Xu, B., and Ghossein, R. (2019). Critical prognostic parameters in the anatomic pathology reporting of differentiated follicular cell-derived thyroid carcinoma. Cancers, 11.","DOI":"10.3390\/cancers11081100"},{"key":"ref_43","first-page":"196","article-title":"The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma","volume":"2","author":"Glover","year":"2013","journal-title":"Gland Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"571421","DOI":"10.3389\/fendo.2020.571421","article-title":"Early diagnosis of low-risk papillary thyroid cancer results rather in overtreatment than a better survival","volume":"11","author":"Krajewska","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.surg.2007.06.011","article-title":"Papillary thyroid carcinoma with distant metastases: Survival predictors and the importance of local control","volume":"143","author":"Sugitani","year":"2008","journal-title":"Surgery"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Toraih, E.A., Hussein, M.H., Zerfaoui, M., Attia, A.S., Ellythy, A.M., Mostafa, A., Ruiz, E., Sharma, M., Russel, J.O., and Randolph, G.W. (2021). Site-specific metastasis and survival in papillary thyroid cancer: The importance of brain and multi-organ disease. Cancers, 13.","DOI":"10.3390\/cancers13071625"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13044-019-0071-3","article-title":"The surgical management of locally advanced well-differentiated thyroid carcinoma: Changes over the years according to the AJCC 8th edition Cancer Staging Manual","volume":"12","author":"Metere","year":"2019","journal-title":"Thyroid Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fendo.2020.00082","article-title":"New therapies for advanced thyroid cancer","volume":"11","author":"Laha","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ijc.33690","article-title":"Thyroid cancer, recent advances in diagnosis and therapy","volume":"149","author":"Nabhan","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1210\/er.2019-00007","article-title":"Targeted therapy for advance thyroid cancer: Kinase inhibitors and beyond","volume":"40","author":"Cabanillas","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"901004","DOI":"10.3389\/fonc.2022.901004","article-title":"Predictive biomarkers in thyroid cancer","volume":"12","author":"Macerola","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1159\/000494080","article-title":"Thrombotic microangiopathy with severe proteinuria induced by Lenvatinib for radioactive iodine-refractory papillary thyroid carcinoma","volume":"11","author":"Hyogo","year":"2018","journal-title":"Case Rep. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1503\/cmaj.160336","article-title":"Well-differentiated thyroid cancer: Thyroidectomy or lobectomy?","volume":"188","author":"Kluijfhout","year":"2016","journal-title":"CMAJ"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Medas, F., Canu, G.L., Cappellacci, F., Anedda, G., Conzo, G., Erdas, E., and Cal\u00f2, P.G. (2020). Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients. Cancers, 12.","DOI":"10.3390\/cancers12061658"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2967\/jnumed.117.195685","article-title":"Iodinated contrast agents perturb iodine uptake by thyroid independent of free iodide","volume":"59","author":"Vassaux","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"De la Vieja, A., and Riesco-Eizaguirre, G. (2021). Radio-iodide treatment from molecular aspects to clinical view. Cancers, 13.","DOI":"10.3390\/cancers13050995"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Sparano, C., Moog, S., Hadoux, J., Dupuy, C., Ghuzlan, A.A., Breuskin, I., Guerlain, J., Hartl, D., Baudin, E., and Lamartina, L. (2022). Strategies for radioiodine treatment: What\u2019s new. Cancers, 14.","DOI":"10.3390\/cancers14153800"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Aashiq, M., Silverman, D.A., Na\u2019ara, S., Takahashi, H., and Amit, M. (2019). Radioiodine-refractory thyroid cancer: Molecular basis of redifferentiation therapies, management, and novel therapies. Cancers, 11.","DOI":"10.3390\/cancers11091382"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"101687","DOI":"10.1016\/j.beem.2022.101687","article-title":"Differentiated thyroid carcinoma: An update","volume":"37","author":"Smit","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ulisse, S., Baldini, E., Lauro, A., Pironi, D., Tripodi, D., Lori, E., Ferent, I.C., Amabile, M.I., Catania, A., and Matteo, F.M.D. (2021). Papillary Thyroid Cancer Prognosis: An Evolving Field. Cancers, 13.","DOI":"10.3390\/cancers13215567"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e17033","DOI":"10.1097\/MD.0000000000017033","article-title":"Papillary thyroid carcinoma with tracheal invasion","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e25280","DOI":"10.1016\/j.heliyon.2024.e25280","article-title":"Microscopic extrathyroidal extension does not affect the prognosis of patients with papillary thyroid carcinoma: A propensity score matching analysis","volume":"10","author":"Jiang","year":"2024","journal-title":"Heliyon"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Coca-Pelaz, A., Rodrigo, J.P., Shah, J.P., Nixon, L.J., Hartl, D.M., Robbins, K.T., Kowalski, L.P., Makitie, A.A., Hamoir, M., and Lopez, F. (2023). Recurrent differentiated thyroid cancer: The current treatment options. Cancers, 15.","DOI":"10.3390\/cancers15102692"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.surg.2013.07.008","article-title":"A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up","volume":"154","author":"Grogan","year":"2013","journal-title":"Surgery"},{"key":"ref_65","first-page":"52","article-title":"Recurrence of papillary thyroid cancer after optimized surgery","volume":"4","author":"CS","year":"2014","journal-title":"Gland Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2014.59.3657","article-title":"BRAF Mutation and Thyroid Cancer Recurrence","volume":"33","author":"Yarchoan","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"9989757","DOI":"10.1155\/2021\/9989757","article-title":"Recurrence Factors and Characteristic Trends of Papillary Thyroid Cancer over Three Decades","volume":"2021","author":"Chatchomchuan","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bj.2021.11.009","article-title":"Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single center observational study in Taiwan","volume":"45","author":"Sun","year":"2022","journal-title":"Biomed. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2010.0178","article-title":"Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify initial risk estimates predicted by the new American Thyroid Association staging system","volume":"20","author":"Tuttle","year":"2010","journal-title":"Thyroid"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/bjs5.50182","article-title":"Impact of the change from seventh to eighth edition of the AJCC TNM classification of malignant tumors and comparison with the MACIS prognostic scoring system in non-medullary thyroid cancer","volume":"3","author":"Dwamena","year":"2019","journal-title":"BJS Open"},{"key":"ref_71","first-page":"1191","article-title":"Oncogenesis of thyroid cancer","volume":"18","author":"Younis","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1038\/s41598-017-04948-3","article-title":"BRAF and NRAS mutations in papillary thyroid carcinoma and concordance in BRAF mutations between primary and corresponding lymph node metastases","volume":"7","author":"Fakhruddin","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Cho, Y., Park, S., Shin, J., Oh, Y., Choe, J., Kim, J., Yim, H., Kim, Y., Ki, C., and Kim, T. (2020). Highly sensitive and specific molecular test for mutations in the diagnosis of thyroid nodules: A prospective study of BRAF-prevalent population. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165629"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Agarwal, S., Bychkov, A., and Jung, C. (2022). Emerging biomarkers in thyroid practic and research. Cancers, 14.","DOI":"10.3390\/cancers14010204"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1111\/jcmm.15007","article-title":"Combined tazemetostat and MAPKi enhances differentiation of thyroid cancer cells harboring BRAFV600E by synergistically decreasing global trimethylation of H3K27","volume":"24","author":"Fu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Santoro, M., Moccia, M., Federico, G., and Carlomagno, F. (2020). RET gene fusions in malignancies of the thyroid and other tissues. Genes, 11.","DOI":"10.3390\/genes11040424"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1611138","DOI":"10.3389\/pore.2023.1611138","article-title":"RET rearrangements are relevant to histopathologic subtypes and clinicopathological features of Thai papillary thyroid carcinoma patients","volume":"29","author":"Khonrak","year":"2023","journal-title":"Pathol. Oncol. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12916-016-0559-9","article-title":"Clinical utility of RAS mutations in thyroid cancer: A blurred picture now emerging clear","volume":"14","author":"Xing","year":"2016","journal-title":"BMC Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Marotta, V., Bifulco, M., and Vitale, M. (2021). Significance of RAS mutations in thyroid benign nodules and non-medullary thyroid cancer. Cancers, 13.","DOI":"10.3390\/cancers13153785"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1634\/theoncologist.2013-0072","article-title":"RAS mutations in thyroid cancer","volume":"18","author":"Howell","year":"2013","journal-title":"Oncologist"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/s41467-019-10680-5","article-title":"Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer","volume":"10","author":"Yoo","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"818204","DOI":"10.1155\/2012\/818204","article-title":"New molecular targeted therapy and redifferentiation therapy for radioiodine-refractory advanced papillary thyroid carcinoma: Literature review","volume":"2012","author":"Wong","year":"2012","journal-title":"J. Thyroid Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of precision cancer medicine: Evolution of the treatment paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sarhadi, V.K., and Armengol, G. (2022). Molecular biomarkers in cancer. Biomolecules, 12.","DOI":"10.3390\/biom12081021"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"DeSouza, N.R., Quaranto, D., Carnazza, M., Jarboe, T., Tiwari, R.K., and Geliebter, J. (2023). Interactome of long-noncoding RNAs: Transcriptomic expression patterns and shaping cancer cell phenotypes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24129914"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"113609","DOI":"10.1016\/j.biopha.2022.113609","article-title":"LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions","volume":"154","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/cen.13369","article-title":"Circulating thyroid cancer biomarkers: Current limitations and future prospects","volume":"87","author":"Nixon","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1218320","DOI":"10.3389\/fendo.2023.1218320","article-title":"New biomarkers: Prospect for diagnosis and monitoring of thyroid disease","volume":"14","author":"Macvanin","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Dadafarin, S., Rodriguez, T., Carnazza, M., Tiwari, R.K., Moscatello, A., and Geliebter, J. (2022). MEG3 Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer. Cells, 11.","DOI":"10.3390\/cells11193181"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2015-2169","article-title":"DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association","volume":"101","author":"Rutter","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3892\/or.2015.4466","article-title":"An integrated analysis of cancer genes in thyroid cancer","volume":"35","author":"Chai","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jasc.2022.11.002","article-title":"A thyroid EIF1AX story: How clinical, cytologic, and molecular surveillance led to appropriate management","volume":"12","author":"Geisler","year":"2023","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_94","first-page":"856","article-title":"Differential expression of galectin-3 in advancing thyroid cancer cells: A clue toward understanding tumour progression and metastasis","volume":"51","author":"Htwe","year":"2010","journal-title":"Singapore Med. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"931647","DOI":"10.3389\/fendo.2022.931647","article-title":"Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma","volume":"13","author":"Banerjee","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/ERC-16-0421","article-title":"Comprehensive screening for PD-L1 expression in thyroid cancer","volume":"24","author":"Ahn","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2016-3756","article-title":"Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study","volume":"102","author":"Chintakuntlawar","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/jcrt.jcrt_1471_22","article-title":"PD-L1 expression in rare and aggressive thyroid cancers: A preliminary investigation for a role of immunotherapy","volume":"19","author":"Boruah","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Shin, E., and Koo, J.S. (2022). Cell component and function of tumor microenvironment in thyroid cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012578"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4646\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:31:45Z","timestamp":1760031105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":99,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104646"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104646","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}